Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 426  

 
   Table of Contents      
ORIGINAL ARTICLE
Year : 2017  |  Volume : 16  |  Issue : 3  |  Page : 218-222

Transient ischemic dilation ratio in regadenoson, single isotope gated single-photon emission computed tomography myocardial perfusion imaging


1 Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA
2 Institute for Heart and Vascular Health, Einstein Medical Center, Philadelphia, PA, USA

Date of Web Publication30-May-2017

Correspondence Address:
Manolo Rubio
Department of Medicine, Einstein Medical Center, 5501 Old York Road, Philadelphia, PA 19141
USA
Login to access the Email id


DOI: 10.4103/1450-1147.207282

PMID: 28670181

Rights and Permissions
   Abstract 

Single isotope 99mTc single-photon emission computed tomography-myocardial perfusion imaging (SPECT-MPI) is the most commonly used protocol for nuclear stress testing. Transient ischemic dilation of the left ventricle (TID) has been considered a specific marker of severe coronary artery disease (CAD). Recent publications have questioned the clinical utility of TID, specifically with regadenoson as a stressor and 4DM-SPECT software for TID analysis. These findings have not been demonstrated using other imaging packages. The goal of our study was to establish the TID threshold in the identification of Multi-vessel CAD using Quantitative Perfusion SPECT (QPS) software. Included in this study are 190 patients that had undergone regadenoson-stress, same day, single-isotope 99mTc MPI and had a coronary angiography within a designated 3-month period. QPS (Cedars-Sinai, LA, CA) automated image analysis software was used to calculate TID ratios which were compared across different CAD categories. Coronary angiograms were reviewed to identify both obstructive and nonobstructive CAD. The mean TID for patients with nonobstructive CAD (n = 91) was 1.02 ± 0.11, and the threshold for TID was 1.24. A receiver operating characteristic curve showed that TID had a poor discriminatory capacity to identify MVD (area under the curve 0.58) with a sensitivity of 3% and a specificity of 97%. In our study with regadenoson MPI in a predominantly African-American population, TID was found to be a poor predictor of MVD using QPS software. The reason is unclear but possibly related to the significant decline in the prevalence of severe CAD in the area where our study took place.

Keywords: Coronary artery disease, myocardial perfusion imaging, regadenoson, single photon emission computed tomography, stress test, transient ischemic dilation


How to cite this article:
Rubio M, Dias A, Koshkelashvili N, Codolosa JN, Jalife-Bucay M, Rodriguez-Ziccardi M, Amanullah AM. Transient ischemic dilation ratio in regadenoson, single isotope gated single-photon emission computed tomography myocardial perfusion imaging. World J Nucl Med 2017;16:218-22

How to cite this URL:
Rubio M, Dias A, Koshkelashvili N, Codolosa JN, Jalife-Bucay M, Rodriguez-Ziccardi M, Amanullah AM. Transient ischemic dilation ratio in regadenoson, single isotope gated single-photon emission computed tomography myocardial perfusion imaging. World J Nucl Med [serial online] 2017 [cited 2021 Jan 25];16:218-22. Available from: http://www.wjnm.org/text.asp?2017/16/3/218/207282


   Introduction Top


Transient ischemic dilation (TID) of the left ventricle has been considered to be a specific marker of severe and extensive coronary artery disease (CAD).[1],[2],[3] Initial studies, with the use of exercise thallium-201, noted that the size of the left ventricle is sometime larger on the immediate poststress image than on the 4 h redistribution image; the phenomenon of which was named “TID of the left ventricle.”[1] Many patients with multivessel CAD have been found to have an abnormal TID, making this finding an easily derived and highly specific marker of multivessel critical stenosis with potential important prognostic value.[1],[4] Several mechanisms are considered responsible for TID on nuclear images; these include subendocardial ischemia, temporary systolic dysfunction or myocardial stunning, and/or a true increase in left ventricular (LV) size.[5] This phenomenon is most often observed after exercise stress,[1] but it has also been found to be present in pharmacologic stress testing with direct coronary vasodilating agents including dipyridamole, adenosine, and dobutamine.[1],[2],[6],[7],[8],[9],[10] Regadenoson was the first selective A2A receptor agonist approved by the Food and Drug Administration as a vasodilator stress agent. It has a rapid onset of action, a short duration; being a selective and potent coronary vasodilator with a good safety profile.[11] Several authors have reported different values for both specificity and sensitivity, as well as different thresholds abnormal TID. This has been done using dipyridamole as a stressor, and, more recently, regadenoson with both, single and dual isotope SPECT.[2],[6],[12],[13],[14] The abnormal TID thresholds described in the past years range from 1.31 to 1.39, with the prior being calculated using regadenoson as a stressor and single-isotope technetium-99m myocardial perfusion imaging-single photon emission computed tomography (MPI-SPECT) and using 4DM-SPECT (4DM) version 5.1 (INVIA-Ann Arbor, MI, USA) as a software package.[14] It is important to mention that the TID thresholds in previous studies have been calculated using either the Emory Cardiac Toolbox (ECTb) or 4DM packages. There have been no previous studies involving Quantitative Perfusion SPECT (QPS) package as a calculating software for TID thresholds. In addition, there are considerable differences between automated quantification software packages in determining an appropriate TID ratio for detection of multivessel CAD, with 4DM showing the highest performance, followed by Cedars QPS, and with the lowest performance ECTb.[15],[16] The objective of our study was to determine the relationship between TID and severity of CAD during regadenoson gated SPECT-MPI single isotope study, using the QPS package (Cedars-Sinai, Los Angeles, CA, USA).


   Methods Top


This study was approved by the Institutional Review Board at Albert Einstein Medical Center, Philadelphia, PA. We reviewed the medical records of 2200 patients' who, between January 2013 and March 2015, underwent clinically indicated regadenoson single isotope myocardial perfusion SPECT imaging using 99m Tc sestamibi as a radiotracer. Only subjects who had a coronary angiogram done within 3 months of the stress test were included in this study. Patients with prior history of coronary artery bypass grafting were excluded from the study. Furthermore, only those patients who had regadenoson as a stress agent were included in the study. Application of such criteria yielded a final sample size of 190 patients. Among this group, TID ratios were obtained and compared in patients with nonobstructive CAD and obstructive CAD, which included single and Multi-vessel CAD.

Single-photon emission computed tomography myocardial perfusion imaging

All subjects underwent 1-day single isotope 99m Tc sestamibi SPECT imaging. The MPI protocol was performed in accordance with the American Society of Nuclear Cardiology guidelines.[17],[18] Rest imaging was performed 45 min after injection of the radiotracer. Pharmacologic stress test was performed with an intravenous injection of 0.4 mg regadenoson, followed by 99m Tc sestamibi injection 25–30 s later.[19] Stress images were acquired 45 min after the second radiotracer injection. All images were acquired utilizing a Philips BrightView Gamma Camera (Phillips Healthcare, Andover, MA, USA); the camera was compliant with the quality control testing according to the recommendations of the manufacturer and the National Electrical Manufacturers Association recommendations for SPECT instrumentation quality control. Both, rest and stress images were electrocardiogram-ungated. The images were carefully chosen and analyzed by an experienced nuclear cardiologist, assuring that the entire myocardium was included, and the axis angles were correct. A careful analysis of the raw SPECT cine images was performed before the interpretation of the reconstructed MPI study to identify potential sources of artifact in the images. For calculation of TID, we used a commercially available automated program (QPS, Cedars-Sinai, Los Angeles, CA, USA), which estimates three dimensional image volumes from gated or ungated SPECT. The algorithm operates in the three-dimensional space and uses the stress and rest short-axis image sets. After calculation of the endocardial volumes (bounded by the endocardial surface and the valve plane), it derives the TID ratio as the ratio of LV volumes at stress and rest. In addition to TID, the following data were calculated automatically: Summed stress score (SSS), summed rest score, end-systolic volume, end-diastolic volume, and ejection fraction (EF). It is worth to mention that the spatial limits for the production of myocardial slices were meticulously selected in an attempt to eliminate all extracardiac activity; thus reducing the risk of errors by the automated software.[20]

Coronary angiography

Coronary angiography was performed as indicated by each patient's primary cardiologist. Each of these procedures was performed and interpreted by well-trained and experienced interventional cardiologists at our institution. Obstructive CAD was defined as ≥70% stenosis in any of three major epicardial arteries or ≥50% stenosis of the left main coronary artery. Fractional flow reserve calculation was used to evaluate the clinical significance of stenosis of intermediate severity. For the purpose of our study, multivessel CAD was defined as obstructive disease in the left main coronary artery or >1 major epicardial vessels.

Statistics

Data analysis was performed with IBM SPSS Statistics for Mac, Version 22.0 (IBM Corp., Armonk, NY, USA). Descriptive statistics were used to analyze the baseline characteristics of the subjects in the study and cross-tabbed with the TID ratio and also with the degree of CAD found on angiography categorized as nonobstructive CAD, single-vessel disease, or Multi-vessel CAD (MVD) including triple vessel disease. Analysis of the categorical variables was achieved using ANOVA, Pearson's Chi-Squared and Fisher's exact test for frequencies <7; other variables were analyzed with a two-tailed Student's t-test; statistical significance was defined as P < 0.05. Logistic regressions, both univariate and multivariate, were used to describe the association between TID and degree of CAD, including MVD, and to calculate appropriate odds ratios (ORs). Regression analysis was used to compare the relationships between the categorical and continuous variables. A receiver operating characteristic (ROC) curve was done to describe the sensitivity and specificity of the TID ratio to predict MVD.


   Results Top


We included 190 subjects who underwent a clinically indicated regadenoson single-isotope MPI SPECT and coronary angiography within 3 months. One hundred and thirteen (59%) were male and the mean age was 62.3 years [standard deviation (SD) 11.9, [Table 1]. The overall prevalence of hypertension was 89%, African-Americans had the highest prevalence of 93%, followed by Caucasians with 88%. Diabetes mellitus was present in 53% of the overall population with a prevalence of 56% in African-Americans and 53% in Caucasians [Table 1] and [Table 2]. The prevalence of nonobstructive CAD in all races was 47% and had a similar prevalence between African-Americans, Caucasians, and Hispanics [Table 3] and [Table 4]. The prevalence of MVD in all races was 27%, with predominance in African-Americans [Table 3] and [Table 4]. Among the group of patients with nonobstructive CAD, 41% had a normal MPI, whereas 51% had an abnormal MPI [Table 4]. The incidence normal and abnormal MPI in the group of MVD was 29% and 28%, respectively. A depressed LVEF <35% was found in 7% of the patients, predominantly among African-Americans [Table 1]. Furthermore, 17% of the patients were found to have severe perfusion defects on the basis of a SSS >13 [Table 1].
Table 1: Demographic characteristics, comorbidities, and myocardial perfusion imaging

Click here to view
Table 2: Race and prevalence of risk factors for coronary artery disease

Click here to view
Table 3: Severity of coronary artery disease and race

Click here to view
Table 4: Severity of coronary artery disease and transient ischemic dilation

Click here to view


The mean TID ratio in patients with nonobstructive CAD was 1.02 (SD 0.11), 1.03 (SD 0.09) for single vessel CAD, and 1.06 (SD 0.09) for multivessel CAD [P = 0.05, [Table 4]. We then determined the abnormal TID ratio threshold after adding 2 SD to the mean TID (1.02, SD 0.11), thus giving a value of 1.24 (after analyzing the population and determining it had a normal Gaussian distribution) [Table 4]. A ROCs curve was done, showing an area under the curve of 0.58, with a confidence interval of 95% (0.499–0.672). In the logistic regression analysis, the OR of TID for prediction of MVD was 1.02 (P = 0.982), the OR of hyperlipidemia for prediction of MVD was 2.73 (P = 0.015), and the OR of history of diabetes for prediction of MVD was 1.42 (P = 0.320). We found no significant correlation between TID, and the MPI scores and ventricular volumes by Pearson's correlation analysis.


   Discussion Top


TID ratio has been previously studied as a predictor of multivessel CAD using several MPI protocols including thallium, sestamibi, and dual and single isotope SPECT.[13],[14] Katz et al. found the threshold for abnormal TID to be 1.39 with a specificity of 95% and a sensitivity of 15% in SPECT MPI with dual isotope.[13] Golzar et al. found the abnormal TID threshold to be 1.31 for single-isotope SPECT MPI using 4DM-SPECT software.[14] Compared with the TID cutoff proposed by Katz et al. for dual-isotope and the one proposed by Golzar et al. for single-isotope, our TID cutoff of 1.24 using QPS software for single-isotope (99mTc) is lower. Our proposed TID cutoff, while similar to those previously reported in other stress protocols, did not provide a significant predictive value in the identification of severe or multivessel CAD.[21] Despite the differences in TID ratios found between patients with low likelihood of CAD and normal MPI, as well as in patients with significant CAD, we did not find any significant clinical correlation. Thus, the TID threshold, we established had no major utility as an identifier of CAD severity. Our outcomes confirm those proposed by Golzar et al. who suggested that TID with regadenoson-stress MPI has questionable clinical utility.[14] These findings could be related to the constant change in CAD prevalence in the state of Pennsylvania, USA, where our study took place, which may include milder clinical presentations of CAD.[22] Of note, there has also been a notable decrease in the frequency of abnormal SPECT-MPI studies in recent years.[23],[24],[25] These factors may contribute to the finding of limited predictive value of TID thresholds. Furthermore, comorbidities in patients such as hypertension, chronic kidney disease, and diabetes may play an important role, not only as risk factors for CAD but also for increased LV end-diastolic pressures resulting in abnormally high TID values with less significant CAD.[26] It is important to consider that the majority of our population was African-American in which there is a statistically higher prevalence of CAD, thus giving a minimal representation of other races. Ours is a single-center study, taking place in a geographical area with an increasing decline in the prevalence of significant CAD.[22] An additional limitation of our study is the exclusive use of one software package. Moreover, our results should be interpreted cautiously and validated by larger multicenter studies given our small sample size. Nevertheless, this is the first study to assess the relevance of TID using the QPS package in this specific protocol.


   Conclusion Top


Recent studies have questioned the additional value of TID to predict the presence of MVD with regadenoson MPI. In our study, with regadenoson MPI in a predominantly African-American population, TID was found to have limited value as a predictor of the existence of MVD based on our analysis using QPS software. The reason is unclear, but possibly related the significant decline in the prevalence of severe CAD in our patient population and select a geographic region (Pennsylvania, USA), where our study took place.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Weiss AT, Berman DS, Lew AS, Nielsen J, Potkin B, Swan HJ, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: A marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752-9.  Back to cited text no. 1
[PUBMED]    
2.
Takeishi Y, Tono-oka I, Ikeda K, Komatani A, Tsuiki K, Yasui S. Dilatation of the left ventricular cavity on dipyridamole thallium-201 imaging: A new marker of triple-vessel disease. Am Heart J 1991;121(2 Pt 1):466-75.  Back to cited text no. 2
    
3.
Halligan WT, Morris PB, Schoepf UJ, Mischen BT, Spearman JV, Spears JR, et al. Transient ischemic dilation of the left ventricle on SPECT: Correlation with findings at coronary CT angiography. J Nucl Med 2014;55:917-22.  Back to cited text no. 3
[PUBMED]    
4.
Veilleux M, Lette J, Mansur A, Bertrand C, Cerino M, Picard M, et al. Prognostic implications of transient left ventricular cavitary dilation during exercise and dipyridamole-thallium imaging. Can J Cardiol 1994;10:259-62.  Back to cited text no. 4
[PUBMED]    
5.
Iskandrian AS, Heo J, Nguyen T, Lyons E, Paugh E. Left ventricular dilatation and pulmonary thallium uptake after single-photon emission computer tomography using thallium-201 during adenosine-induced coronary hyperemia. Am J Cardiol 1990;66:807-11.  Back to cited text no. 5
[PUBMED]    
6.
Chouraqui P, Rodrigues EA, Berman DS, Maddahi J. Significance of dipyridamole-induced transient dilation of the left ventricle during thallium-201 scintigraphy in suspected coronary artery disease. Am J Cardiol 1990;66:689-94.  Back to cited text no. 6
[PUBMED]    
7.
Lette J, Bertrand C, Gossard D, Ruscito O, Cerino M, McNamara D, et al. Long-term risk stratification with dipyridamole imaging. Am Heart J 1995;129:880-6.  Back to cited text no. 7
[PUBMED]    
8.
McClellan JR, Travin MI, Herman SD, Baron JI, Golub RJ, Gallagher JJ, et al. Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events. Am J Cardiol 1997;79:600-5.  Back to cited text no. 8
[PUBMED]    
9.
Heston TF, Sigg DM. Quantifying transient ischemic dilation using gated SPECT. J Nucl Med 2005;46:1990-6.  Back to cited text no. 9
[PUBMED]    
10.
Yao SS, Shah A, Bangalore S, Chaudhry FA. Transient ischemic left ventricular cavity dilation is a significant predictor of severe and extensive coronary artery disease and adverse outcome in patients undergoing stress echocardiography. J Am Soc Echocardiogr 2007;20:352-8.  Back to cited text no. 10
[PUBMED]    
11.
Al Jaroudi W, Iskandrian AE. Regadenoson: A new myocardial stress agent. J Am Coll Cardiol 2009;54:1123-30.  Back to cited text no. 11
[PUBMED]    
12.
Abidov A, Bax JJ, Hayes SW, Hachamovitch R, Cohen I, Gerlach J, et al. Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol 2003;42:1818-25.  Back to cited text no. 12
[PUBMED]    
13.
Katz JS, Ruisi M, Giedd KN, Rachko M. Assessment of transient ischemic dilation (TID) ratio in gated SPECT myocardial perfusion imaging (MPI) using regadenoson, a new agent for pharmacologic stress testing. J Nucl Cardiol 2012;19:727-34.  Back to cited text no. 13
[PUBMED]    
14.
Golzar Y, Olusanya A, Pe N, Dua SG, Golzar J, Gidea C, et al. The significance of automatically measured transient ischemic dilation in identifying severe and extensive coronary artery disease in regadenoson, single-isotope technetium-99m myocardial perfusion SPECT. J Nucl Cardiol 2015;22:526-34.  Back to cited text no. 14
[PUBMED]    
15.
Guner LA, Karabacak NI, Cakir T, Akdemir OU, Kocaman SA, Cengel A, et al. Comparison of diagnostic performances of three different software packages in detecting coronary artery disease. Eur J Nucl Med Mol Imaging 2010;37:2070-8.  Back to cited text no. 15
[PUBMED]    
16.
Johansson L, Lomsky M, Marving J, Ohlsson M, Svensson SE, Edenbrandt L. Diagnostic evaluation of three cardiac software packages using a consecutive group of patients. EJNMMI Res 2011;1:22.  Back to cited text no. 16
[PUBMED]    
17.
Henzlova MJ, Cerqueira MD, Mahmarian JJ, Yao SS; Quality Assurance Committee of the American Society of Nuclear Cardiology. Stress protocols and tracers. J Nucl Cardiol 2006;13:e80-90.  Back to cited text no. 17
[PUBMED]    
18.
Bokhari S, Ficaro EP, McCallister BD Jr. Adenosine stress protocols for myocardial perfusion imaging. J Nucl Cardiol 2007;14:415-6.  Back to cited text no. 18
[PUBMED]    
19.
Astellas Pharma. Lexiscan ® (regadenoson): Full prescribing information. Deerfield, IL, USA. 2011. Available from: https://www.astellas.us/docs/lexiscan.pdf. [Last accessed on 2015 Sep 14].  Back to cited text no. 19
    
20.
Danias PG, Ahlberg AW, Travin MI, Mahr NC, Abreu JE, Marini D, et al. Visual assessment of left ventricular perfusion and function with electrocardiography-gated SPECT has high intraobserver and interobserver reproducibility among experienced nuclear cardiologists and cardiology trainees. J Nucl Cardiol 2002;9:263-70.  Back to cited text no. 20
[PUBMED]    
21.
Abidov A, Germano G, Berman DS. Transient ischemic dilation ratio: A universal high-risk diagnostic marker in myocardial perfusion imaging. J Nucl Cardiol 2007;14:497-500.  Back to cited text no. 21
[PUBMED]    
22.
Health PDo (2008) Chronic Disease Burden Report. Pennsylvania Department of Health; 2008. Available from: http://www.health.pa.gov/migration/Documents/ChronicDiseaseBurdenReport.pdf. [Last accessed on 2015 Nov 10].  Back to cited text no. 22
    
23.
Beller GA. Decrease in the frequency of stress-induced ischemia over the past two decades. J Nucl Cardiol 2013;20:322-3.  Back to cited text no. 23
[PUBMED]    
24.
Iskandrian AE, Hage FG. Declining frequency of ischemia detection using stress myocardial perfusion imaging. J Am Coll Cardiol 2013;61:1066-8.  Back to cited text no. 24
[PUBMED]    
25.
Rozanski A, Gransar H, Hayes SW, Min J, Friedman JD, Thomson LE, et al. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol 2013;61:1054-65.  Back to cited text no. 25
[PUBMED]    
26.
Elhabyan AK, Reyes BJ, Hallak O, Broce M, Rosencrance JG, Lucas BD, et al. Subendocardial ischemia without coronary artery disease: Is elevated left ventricular end diastolic pressure the culprit? Curr Med Res Opin 2004;20:773-7.  Back to cited text no. 26
[PUBMED]    



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]


This article has been cited by
1 How variable are the volumetric measurements from gated perfusion SPECT when a one-day stress-rest protocol is used?
C. Fielder Camm,Alexander Emery,Elizabeth Rose-Innes,Sergei Pavlitchouk,Nikant Sabharwal,Andrew D. Kelion
Journal of Nuclear Cardiology. 2018;
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
   Methods
   Results
   Discussion
   Conclusion
    References
    Article Tables

 Article Access Statistics
    Viewed2121    
    Printed48    
    Emailed0    
    PDF Downloaded230    
    Comments [Add]    
    Cited by others 1    

Recommend this journal